As South Africa observes Cervical Cancer Elimination Day of Action, efforts are ongoing to reduce the high incidence of the disease in the country.
Globally, cervical cancer is a major global health challenge, with 660,000 new cases and around 350,000 deaths reported in 2022. Locally, 13,800 new cases of cervical cancer are diagnosed annually, making it the second most common cancer in South African women.
As the world marks the Cervical Cancer Elimination Day of Action, South Africa reports promising outcomes from its HPV vaccination campaign.
In response to this crisis, the DoH launched its Human Papillomavirus (HPV) vaccination campaign in 2014, targeting girls in Grade 5 (aged 9 years and older) in public and special schools.
Since its launch, the program has achieved significant coverage. To date, over 7.1 million doses have been administered, protecting more than 4 million girls. Approximately 85% of girls aged 9-15 in public schools and around 75% of all girls in this age group nationwide have been vaccinated, demonstrating the campaign's widespread reach and effectiveness.
The programme was extended to private schools in 2024 to ensure broader coverage.
The success of the HPV vaccination rollout is attributed to strong political commitment, collaboration between Health and Education Ministries, and dedicated funding from National Treasury.
Despite progress in vaccination, cervical screening and treatment lag, prompting the Department of Health to expand HPV testing, now active in 17 out of 52 districts, with plans for further rollout.
Additionally, the Department of Health, in collaboration with the World Health Organization, is conducting capacity training for clinicians to enhance their skills in cervical cancer screening, diagnosis, and treatment.
The Department of Health has called on parents to ensure eligible girls receive missed doses at public health facilities to enhance protection against cervical cancer.